![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sweden’s OssDsign Buys Bone-Graft Developer Sirakoss for $11 Million
Sweden’s OssDsign Buys Bone-Graft Developer Sirakoss for $11 Million
Swedish devicemaker OssDsign has acquired UK-based Sirakoss, the developer of Osteo3 ZP Putty, for $11 million plus additional milestone and royalty payments.
Sirakoss’ Osteo3 ZP Putty, a synthetic bone-graft substitute used for bone repair, received 510(k) marketing clearance from the FDA in June. The putty is used to fill voids during spine and trauma bone-grafting procedures and to promote rapid bone growth.
OssDsign said it will begin marketing the bone-graft product in the U.S. immediately.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct